ebook img

Streptococcus (Group A) (Deadly Diseases and Epidemics) PDF

113 Pages·2004·1.83 MB·English
Save to my drive
Quick download
Download
Most books are stored in the elastic cloud where traffic is expensive. For this reason, we have a limit on daily download.

Preview Streptococcus (Group A) (Deadly Diseases and Epidemics)

STREPTOCOCCUS (GROUP A) Anthrax Meningitis Campylobacteriosis Mononucleosis Cholera Plague Escherichia coli Polio Infections SARS Gonorrhea Smallpox Hepatitis Streptococcus Herpes (Group A) HIV/AIDS Syphilis Influenza Toxic Shock Lyme Disease Syndrome Mad Cow Disease Tuberculosis (Bovine Spongiform Encephalopathy) Typhoid Fever Malaria West Nile Virus STREPTOCOCCUS (GROUP A) Tara C. Smith CONSULTING EDITOR The Late I. Edward Alcamo The Late Distinguished Teaching Professor of Microbiology, SUNY Farmingdale FOREWORD BY David Heymann World Health Organization COVER:Photomicrograph ofStreptococcusbacteria,taken with a scanning electron microscope,magnified 9,000 times. Dedication We dedicate the books in the DEADLYDISEASESANDEPIDEMICSseries to Ed Alcamo, whose wit,charm,intelligence,and commitment to biology education were second to none. CHELSEA HOUSE PUBLISHERS VP,NEWPRODUCTDEVELOPMENT Sally Cheney DIRECTOROFPRODUCTION Kim Shinners CREATIVEMANAGERTakeshi Takahashi MANUFACTURINGMANAGER Diann Grasse Staff for Streptococcus (Group A) EXECUTIVEEDITORTara Koellhoffer ASSOCIATEEDITORBeth Reger PRODUCTIONEDITORNoelle Nardone PHOTOEDITORSarah Bloom SERIESDESIGNERTerry Mallon COVERDESIGNERKeith Trego LAYOUT21st Century Publishing and Communications,Inc. ©2005 by Chelsea House Publishers, a subsidiary ofHaights Cross Communications. All rights reserved.Printed and bound in the United States ofAmerica. http://www.chelseahouse.com First Printing 1 3 5 7 9 8 6 4 2 Library ofCongress Cataloging-in-Publication Data Smith,Tara C.,1976 Streptococcus (group A)/Tara C.Smith. p.cm.(Deadly diseases and epidemics) Includes bibliographical references and index. ISBN 0-7910-7901-5—ISBN 0-7910-8346-2 (pbk.) 1.Streptococcal infections.2.Streptococcus.3.Necrotizing fasciitis.I.Title. II.Series. QR201.S7S63 2004 616.9'298dc22 2004010502 All links and web addresses were checked and verified to be correct at the time ofpublication.Because ofthe dynamic nature ofthe web,some addresses and links may have changed since publication and may no longer be valid. Table of Contents Foreword David Heymann, World Health Organization 6 1. One Bacterium, Many Different Diseases 8 2. Basic Microbiology, Diagnosis, and Treatment of the Group A Streptococcus 18 3. Superficial Infections: Streptococcal Pharyngitis and Impetigo 28 4. Scarlet Fever 34 5. Resurgence of an Old Pathogen: Invasive Streptococcal Diseases 44 6. Post-Streptococcal Complications 54 7. Virulence Factors of Group A Streptococci 66 8. Vaccine Prospects and the Future of the Group A Streptococcus 86 Glossary 92 Bibliography 100 Further Reading 104 Websites 105 Index 106 Foreword In the 1960s, many of the infectious diseases that had terrorized generations were tamed. After a century of advances, the leading killers ofAmericans both young and old were being prevented with new vaccines or cured with new medicines.The risk ofdeath from pneumonia, tuberculosis (TB), meningitis, influenza, whooping cough,and diphtheria declined dramatically.New vaccines lifted the fear that summer would bring polio,and a global campaign was on the verge of eradicating smallpox worldwide. New pesticides like DDT cleared mosquitoes from homes and fields,thus reducing the incidence of malaria,which was present in the southern United States and which remains a leading killer of children worldwide. New technologies produced safe drinking water and removed the risk of cholera and other water-borne diseases. Science seemed unstoppable.Disease seemed destined to all but disappear. But the euphoria ofthe 1960s has evaporated. The microbes fought back. Those causing diseases like TB and malaria evolved resistance to cheap and effective drugs.The mosquito developed the ability to defuse pesticides.New diseases emerged, including AIDS, Legionnaires, and Lyme disease. And diseases which had not been seen in decades re-emerged, as the hantavirus did in the Navajo Nation in 1993. Technology itself actually created new health risks. The global transportation network, for example, meant that diseases like West Nile virus could spread beyond isolated regions and quickly become global threats.Even modern public health protections sometimes failed, as they did in 1993 in Milwaukee,Wisconsin,resulting in 400,000 cases of the digestive system illness cryptosporidiosis. And, more recently,the threat from smallpox,a disease believed to be completely eradicated, has returned along with other potential bioterrorism weapons such as anthrax. The lesson is that the fight against infectious diseases will never end. In our constant struggle against disease, we as individuals have a weapon that does not require vaccines or drugs, and that is the warehouse of knowledge.We learn from the history of sci- 6 ence that “modern” beliefs can be wrong. In this series of books, for example, you will learn that diseases like syphilis were once thought to be caused by eating potatoes.The inven- tion of the microscope set science on the right path.There are more positive lessons from history.For example,smallpox was eliminated by vaccinating everyone who had come in contact with an infected person. This “ring” approach to smallpox control is still the preferred method for confronting an outbreak,should the disease be intentionally reintroduced. At the same time,we are constantly adding new drugs,new vaccines,and new information to the warehouse.Recently,the entire human genome was decoded.So too was the genome of the parasite that causes malaria. Perhaps by looking at the microbe and the victim through the lens of genetics we will be able to discover new ways to fight malaria,which remains the leading killer of children in many countries. Because ofadvances in our understanding ofsuch diseases as AIDS, entire new classes of anti-retroviral drugs have been developed.But resistance to all these drugs has already been detected, so we know that AIDS drug development must continue. Education, experimentation, and the discoveries that grow out ofthem are the best tools to protect health.Opening this book may put you on the path of discovery. I hope so, because new vaccines,new antibiotics,new technologies,and, most importantly, new scientists are needed now more than ever if we are to remain on the winning side of this struggle against microbes. David Heymann Executive Director Communicable Diseases Section World Health Organization Geneva,Switzerland 7 1 One Bacterium, Many Different Diseases The group A beta-hemolytic streptococcus (GABHS; species name, Streptococcus pyogenes) is a species of bacteria that can cause a wide variety of diseases. Some of these diseases may be superficial (non- lethal) diseases, such as pharyngitis (“strep throat”) and impetigo (a skin disease). However, infections caused by some strains (isolates that are identical at the genetic level) of this type of bacterium can also cause diseases with a high fatality rate,suchas necrotizing fasciitis (NF) and streptococcal toxic shock syndrome (STSS).In addition,diseases caused by these bacteria do not necessarily stop affecting the person when the infection is eliminated.Indeed,some diseases only begin to manifest symptoms days or weeks after thebacteria have been cleared from the body.These delayed diseases,called postinfection sequelae, are most often due to an aberrant immune response by the host. Some postinfection sequelae include glomerulonephritis (a disease of the kidneys), rheumatic fever, and rheumatic heart disease. The group A streptococcus is also able to cause scarlet fever,which is a rash caused by toxins produced by the bacteriaduring a throat infection;and puerperal fever,which is an infection ofthe blood that was,at one time, a leading cause ofmortality among women who had recently given birth. One aspect of the biology of group A streptococci that is both interesting about this group of bacteria, as well as frustrating to those who study it,is that the epidemiology(study ofdisease patterns) ofthe organisms has changed over time.For example,during some points in history,infection with a group A streptococci almost always resulted in 8 CH.DDE.Str.C01.Final.q 7/2/04 6:31 PM Page 9 only a mild disease,such as pharyngitis.However,at other times, group A streptococci were the causative agents of deadly epidemics,which could result in the death of every child in a family. Most recently, a resurgence of severe 9

See more

The list of books you might like

Most books are stored in the elastic cloud where traffic is expensive. For this reason, we have a limit on daily download.